Therapeutic potential of JAK/STAT pathway modulation in mood disorders

References

Banerjee, S., Biehl, A., Gadina, M., Hasni, S., and Schwartz, D.M. (2017). JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 5, 521–546.10.1007/s40265-017-0701-9Search in Google Scholar PubMed PubMed Central

Ben Haim, L., Ceyzériat, K., Carrillo-de Sauvage, M.A., Aubry, F., Auregan, G., Guillermier, M., Ruiz, M., Petit, F., Houitte, D., Faivre, E., et al. (2015). The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer’s and Huntington’s diseases. J. Neurosci. 6, 2817–2829.10.1523/JNEUROSCI.3516-14.2015Search in Google Scholar PubMed PubMed Central

Brietzke, E., Stertz, L., Fernandes, B.S., Kauer-Sant’anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J.A., and Kapczinski, F. (2009). Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J. Affect. Disord. 3, 214–217.10.1016/j.jad.2008.12.001Search in Google Scholar PubMed

Calcia, M.A., Bonsall, D.R., Bloomfield, P.S., Selvaraj, S., Barichello, T., and Howes, O.D. (2016). Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl.) 9, 1637–1650.10.1007/s00213-016-4218-9Search in Google Scholar PubMed PubMed Central

Chang, C., Zhao, Y., Song, G., and She, K. (2018). Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats. J. Neuroimmunol. 315, 9–14.10.1016/j.jneuroim.2017.11.015Search in Google Scholar PubMed

Cianciulli, A., Dragone, T., Calvello, R., Porro, C., Trotta, T., Lofrumento, D.D., and Panaro, M.A. (2015). IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int. Immunopharmacol. 2, 369–376.10.1016/j.intimp.2014.12.035Search in Google Scholar PubMed

Curtis, J.R., Lee, E.B., Kaplan, I.V., Kwok, K., Geier, J., Benda, B., Soma, K., Wang, L., and Riese, R. (2016). Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme. Ann. Rheum. Dis. 5, 831–841.10.1136/annrheumdis-2014-205847Search in Google Scholar PubMed PubMed Central

Deisseroth, A., Kaminskas, E., Grillo, J., Chen, W., Saber, H., Lu, H.L., Rothmann, M.D., Brar, S., Wang, J., Garnett, C., et al. (2012). U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis. Clin. Cancer Res. 12, 3212–3217.10.1158/1078-0432.CCR-12-0653Search in Google Scholar PubMed

Eyre, H. and Baune, B.T. (2012). Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 9, 1397–1416.10.1016/j.psyneuen.2012.03.019Search in Google Scholar PubMed

Fond, G., Hamdani, N., Kapczinski, F., Boukouaci, W., Drancourt, N., Dargel, A., Oliveira, J., Le Guen, E., Marlinge, E., Tamouza, R., et al. (2014). Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr. Scand. 129, 163–179.10.1111/acps.12211Search in Google Scholar PubMed

Glaus, J., Vandeleur, C.L., von Känel, R., Lasserre, A.M., Strippoli, M.P., Gholam-Rezaee, M., Castelao, E., Marques-Vidal, P., Bovet, P., Merikangas, K., et al. (2014). Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study. J. Psychiatr. Res. 58, 36–45.10.1016/j.jpsychires.2014.07.012Search in Google Scholar PubMed

Goswami, R. and Kaplan, M.H. (2017). STAT transcription factors in T cell control of health and disease. Int. Rev. Cell Mol. Biol. 331, 123–180.10.1016/bs.ircmb.2016.09.012Search in Google Scholar PubMed

Gulbins, A., Grassmé, H., Hoehn, R., Kohnen, M., Edwards, M.J., Kornhuber, J., and Gulbins, E. (2016). Role of Janus-Kinases in major depressive disorder. Neurosignals 24, 71–80.10.1159/000442613Search in Google Scholar PubMed

Hinwood, M., Morandini, J., Day, T.A., and Walker, F.R. (2012). Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb. Cortex 22, 1442–1454.10.1093/cercor/bhr229Search in Google Scholar PubMed

Hofmann, H.D. and Kirsch, M. (2012). JAK2-STAT3 signaling: a novel function and a novel mechanism. JAKSTAT 3, 191–193.10.4161/jkst.20446Search in Google Scholar PubMed PubMed Central

Howes, O.D. and McCutcheon, R. (2017). Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl. Psychiatry 2, 1024.10.1038/tp.2016.278Search in Google Scholar PubMed PubMed Central

Jatiani, S.S., Baker, S.J., Silverman, L.R., and Reddy, E.P. (2010). JAK/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer 10, 979–993.10.1177/1947601910397187Search in Google Scholar PubMed PubMed Central

Jha, M.K., Minhajuddin, A., Gadad, B.S., Greer, T.L., Mayes, T.L., and Trivedi, M.H. (2017). Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: novel T cell biomarker for antidepressant medication selection. Brain Behav. Immun. 66, 103–110.10.1016/j.bbi.2017.07.005Search in Google Scholar PubMed PubMed Central

Joormann, J. and Quinn, M.E. (2014). Cognitive processes and emotion regulation in depression. Depress Anxiety 4, 308–315.10.1002/da.22264Search in Google Scholar PubMed

Lemmon, M.A. and Schlessinger, J. (2010). Cell signaling by receptor-tyrosine kinases. Cell 7, 1117–1134.10.1016/j.cell.2010.06.011Search in Google Scholar PubMed PubMed Central

Leonard, W.J. (2001). Role of Jak kinases and STATs in cytokine signal transduction. Int. J. Hematol. 3, 271–277.10.1007/BF02981951Search in Google Scholar PubMed

Mahar, I., Bambico, F.R., Mechawar, N., and Nobrega, J.N. (2014). Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci. Biobehav. Rev. 38, 173–192.10.1016/j.neubiorev.2013.11.009Search in Google Scholar PubMed

Malemud, C.J. and Miller, A.H. (2008). Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin. Ther. Targets 12, 171–183.10.1517/14728222.12.2.171Search in Google Scholar PubMed

McNamara, R.K. and Lotrich, F.E. (2012). Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev. Neurother. 12, 1143–1161.10.1586/ern.12.98Search in Google Scholar PubMed PubMed Central

Meyer, J.H. (2017). Neuroprogression and immune activation in major depressive disorder. Mod. Trends Pharmacopsychiatry 31, 27–36.10.1159/000470804Search in Google Scholar PubMed

Miller, A.H. (2010). Depression and immunity: a role for T cells? Brain Behav. Immun. 1, 1–8.Search in Google Scholar

Miller, A.H., Haroon, E., Raison, C.L., and Felger, J.C. (2013). Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 4, 297–306.10.1002/da.22084Search in Google Scholar PubMed PubMed Central

Motivala, S.J., Sarfatti, A., Olmos, L., and Irwin, M.R. (2005). Inflammatory markers and sleep disturbance in major depression. Psychosom. Med. 67, 187–19410.1097/01.psy.0000149259.72488.09Search in Google Scholar PubMed

Nicolas, C.S., Peineau, S., Amici, M., Csaba, Z., Fafouri, A., Javalet, C., Collett, V.J., Hildebrandt, L., Seaton, G., Choi, S.L., et al. (2012). The Jak/STAT pathway is involved in synaptic plasticity. Neuron 73, 374–390.10.1016/j.neuron.2011.11.024Search in Google Scholar PubMed PubMed Central

O’Shea, J.J. and Robert Plenge, R. (2012). JAKs and STATs in immunoregulation and immune-mediated disease. Immunity 4, 542–550.10.1016/j.immuni.2012.03.014Search in Google Scholar PubMed PubMed Central

Panés, J., Su, C., Bushmakin, A.G., Cappelleri, J.C., Mamolo, C., and Healey, P. (2015). Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes. BMC Gastroenterol. 5, 15.10.1186/s12876-015-0239-9Search in Google Scholar PubMed PubMed Central

Panés, J., Vermeire, S., Lindsay, J.O., Sands, B.E., Su, C., Friedman, G., Zhang, H., Yarlas, A., Bayliss, M., Maher, S., et al. (2018). Tofacitinib in patients with ulcerative colitis: health-related quality of life in phase 3 randomised controlled induction and maintenance studies. J. Crohns Colitis 2, 145–156.10.1093/ecco-jcc/jjx133Search in Google Scholar PubMed PubMed Central

Patton, M.S., Lodge, D.J., Morilak, D.A., and Girotti, M. (2017). Ketamine corrects stress-induced cognitive dysfunction through JAK2/STAT3 signaling in the orbitofrontal cortex. Neuropsychopharmacology 6, 1220–1230.10.1038/npp.2016.236Search in Google Scholar PubMed PubMed Central

Qin, H., Buckley, J.A., Li, X., Liu, Y., Fox, T.H., Meares, G.P., Yu, H., Yan, Z., Harms, A.S., Li, Y., et al. (2016). Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J. Neurosci. 18, 5144–5159.10.1523/JNEUROSCI.4658-15.2016Search in Google Scholar PubMed PubMed Central

Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., and Miller, A.H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 70, 31–41.10.1001/2013.jamapsychiatry.4Search in Google Scholar PubMed PubMed Central

Rawlings, J.S., Rosler, K.M., and Harrison, D.A. (2004). The JAK/STAT signaling pathway. J. Cell Sci. 117, 1281–1283.10.1242/jcs.00963Search in Google Scholar PubMed

Rosenblat, J.D., Brietzke, E., Mansur, R.B., Maruschak, N.A., Lee, Y., and McIntyre, R.S. (2015). Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J. Affect. Disord. 188, 149–159.10.1016/j.jad.2015.08.058Search in Google Scholar PubMed

Rosenblat, J.D., Kakar, R., Berk, M., Kessing, L.V., Vinberg, M., Baune, B.T., Mansur, R.B., Brietzke, E., Goldstein, B.I., and McIntyre, R.S. (2016). Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disord. 2, 89–101.10.1111/bdi.12373Search in Google Scholar PubMed

Sarafian, T.A., Montes, C., Imura, T., Qi, J., Coppola, G., Geschwind, D.H., and Sofroniew, M.V. (2010). Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS One 10, 5.10.1371/journal.pone.0009532Search in Google Scholar PubMed PubMed Central

Schiff, M., Takeuchi, T., Fleischmann, R., Gaich, C.L., DeLozier, A.M., Schlichting, D., Kuo, W.L., Won, J.E., Carmack, T., Rooney, T., et al. (2017). Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Res. Ther. 1, 208.10.1186/s13075-017-1410-1Search in Google Scholar PubMed PubMed Central

Seif, F., Khoshmirsafa, M., Aazami, H., Mohsenzadegan, M., Sedighi, G., and Bahar, M. (2017). The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun. Signal. 15, 23.10.1186/s12964-017-0177-ySearch in Google Scholar PubMed PubMed Central

Shariq, A.S., Brietzke, E., Rosenblat, J.D., Barendra, V., Pan, Z., and McIntyre, R.S. (2018). Targeting cytokines in reduction of depressive symptoms: a comprehensive review. Prog. Neuropsychopharmacol. Biol. Psychiatry 83, 86–91.10.1016/j.pnpbp.2018.01.003Search in Google Scholar PubMed

Skarica, M., Wang, T., McCadden, E., Kardian, D., Calabresi, P.A., Small, D., and Whartenby, K.A. (2009). Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis. J. Immunol. 182, 4192–4199.10.4049/jimmunol.0803631Search in Google Scholar PubMed PubMed Central

Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., and Cleare, A.J. (2015). Inflammation and clinical response to treatment in depression: a meta-analysis. Eur. Neuropsychopharmacol. 10, 1532–1543.10.1016/j.euroneuro.2015.06.007Search in Google Scholar PubMed

Talarowska, M., Zajączkowska, M., and Gałecki. P. (2015). Cognitive functions in first-episode depression and recurrent depressive disorder. Psychiatr. Danub. 27, 38–43.Search in Google Scholar PubMed

Traynor, K. (2012). FDA approves tofacitinib for rheumatoid arthritis. Am. J. Health Syst. Pharm. 24, 2120.10.2146/news120088Search in Google Scholar PubMed

Tynan, R.J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K.M., Pow, D.V., Day, T.A., and Walker, F.R. (2010). Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 24, 1058–1068.10.1016/j.bbi.2010.02.001Search in Google Scholar PubMed

Videbech, P. and Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 11, 1957–1966.10.1176/appi.ajp.161.11.1957Search in Google Scholar PubMed

Weinberger, J.F., Raison, C.L., Rye, D.B., Montague, A.R., Woolwine, B.J., Felger, J.C., Haroon, E., and Miller, A.H. (2015). Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. Brain Behav. Immun. 47, 193–200.10.1016/j.bbi.2014.12.016Search in Google Scholar PubMed PubMed Central

Whartenby, K.A., Calabresi, P.A., McCadden, E., Nguyen, B., Kardian, D., Wang, T., Mosse, C., Pardoll, D.M., and Small, D. (2005). Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc. Natl. Acad. Sci. USA 102, 16741–16746.10.1073/pnas.0506088102Search in Google Scholar PubMed PubMed Central

Wiener, C.D., Moreira, F.P., Cardoso, T.A., Mondin, T.C., da Silva Magalhães, P.V., Kapczinski, F., de Mattos Souza, L.D., da Silva, R.A., Oses, J.P., and Jansen, K. (2017). Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder. J. Neuroimmunol. 307, 33–36.10.1016/j.jneuroim.2017.03.003Search in Google Scholar PubMed

Winthrop, K.L. (2017). The emerging safety profile of JAK inhibitors in rheumatic disease. Nat. Rev. Rheumatol. 4, 234–243.10.1038/nrrheum.2017.23Search in Google Scholar PubMed

Winthrop, K.L., Park, S.H., Gul, A., Cardiel, M.H., Gomez-Reino, J.J., Tanaka, Y., Kwok, K., Lukic, T., Mortensen, E., Ponce de Leon, D., et al. (2016). Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Ann. Rheum. Dis. 6, 1133–1138.10.1136/annrheumdis-2015-207319Search in Google Scholar PubMed PubMed Central

Yirmiya, R., Rimmerman, N., and Reshef, R. (2015). Depression as a microglial disease. Trends Neurosci. 10, 637–658.10.1016/j.tins.2015.08.001Search in Google Scholar PubMed